{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Automatic summarization of science publication texts, machine learning based.\n",
    "\n",
    "#### Including:\n",
    "- Text Preprocessing\n",
    "- KeyWords extraction\n",
    "- Syntactic Parsing. Part of speech tagging\n",
    "- Word Embedding (text vectors). \n",
    "- Word2Vec Model Visualisation\n",
    "- TF – IDF matrices \n",
    "- Search cosine similarity between documents\n",
    "- Five different algorithms for construction of summaries: \n",
    "    improved \"TextRank\" from Gensim, usual TextRank, LSA, Kullback–Leibler, LexRank"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package stopwords to\n",
      "[nltk_data]     C:\\Users\\kvoronaya\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package stopwords is already up-to-date!\n",
      "[nltk_data] Downloading package wordnet to\n",
      "[nltk_data]     C:\\Users\\kvoronaya\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package wordnet is already up-to-date!\n"
     ]
    }
   ],
   "source": [
    "# Word2Vec model (word embeddings).\n",
    "from gensim.models import Word2Vec\n",
    "\n",
    "# This summarizer is based on the improved \"TextRank\" algorithm, and uses \"BM25 ranking function\".\n",
    "from gensim.summarization import summarize, keywords\n",
    "\n",
    "# Four different algorithms: usual TextRank, LSA, Kullback–Leibler, LexRank.\n",
    "from sumy.summarizers.text_rank import TextRankSummarizer as TextRankSummarizer\n",
    "from sumy.summarizers.lsa import LsaSummarizer as Summarizer\n",
    "from sumy.summarizers.kl import KLSummarizer as KL\n",
    "from sumy.summarizers.lex_rank import LexRankSummarizer as LRS\n",
    "\n",
    "# Used for text preprocessing.\n",
    "from sumy.parsers.plaintext import PlaintextParser\n",
    "from sumy.nlp.tokenizers import Tokenizer\n",
    "from sumy.nlp.stemmers import Stemmer\n",
    "from sumy.utils import get_stop_words\n",
    "\n",
    "# ROUGE - set of metrics used for evaluating automatic summarization.\n",
    "import sumy.evaluation.rouge as Rogue\n",
    "\n",
    "# Using for search cosine similarity between documents - articles.\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "\n",
    "# Term Frequency – Inverse Document Frequency (TF – IDF).\n",
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "\n",
    "# t-distributed Stochastic Neighbor Embedding.\n",
    "from sklearn.manifold import TSNE\n",
    "\n",
    "# Used for text preprocessing and part of speech tagging.\n",
    "import nltk\n",
    "from nltk import word_tokenize, pos_tag\n",
    "from nltk.corpus import stopwords\n",
    "from nltk.stem.lancaster import LancasterStemmer\n",
    "from nltk.stem import WordNetLemmatizer\n",
    "\n",
    "# Download NLTK corpuses.\n",
    "nltk.download(\"stopwords\")\n",
    "nltk.download('wordnet')\n",
    "\n",
    "import os\n",
    "import string\n",
    "\n",
    "# Used for data representation.\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "# Used for visualisation.\n",
    "import matplotlib.pyplot as plt\n",
    "import pylab as pyl"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "PATH_TEST_SET = 'G:/vkr_docs_to_start/shizic_articles_test_set/test_set_vkr/'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "***** File Name Mapping *****\n",
      "0: \"Use of Acetaminophen (Paracetamol) During Pregnancy .txt\"\n",
      "1: \"Care for Adolescents with Depression in Primary Care Settings.txt\"\n",
      "2: \"Short-term Suicide Risk After Psychiatric Hospital Discharge.txt\"\n",
      "3: \"Association of Hormonal Contraception With Depression.txt\"\n",
      "4: \"Exaggerated Acquisition and Resistance to Extinction of Avoidance Behavior in Treated Heroin-Dependent Men.txt\"\n",
      "5: \"Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia.txt\"\n",
      "6: \"Cigarette Smoking and the Onset and Persistence of Panic Attacks During Mid-Adulthood in the United States.txt\"\n",
      "7: \"Behavioral Interventions for Antipsychotic Medication Associated Obesity.txt\"\n",
      "8: \"Treatment Preferences of Psychotherapy Patients with Chronic PTSD.txt\"\n",
      "9: \"Efficacy of Topiramate in the Treatment of Crack Cocaine Dependence.txt\"\n"
     ]
    }
   ],
   "source": [
    "file_name_mapping = {}\n",
    "test_set = []\n",
    "count = 0\n",
    "\n",
    "for file in os.listdir(PATH_TEST_SET):\n",
    "    if file.endswith(\".txt\"):\n",
    "        file_name_mapping[count] = file\n",
    "        count += 1\n",
    "        f = open(PATH_TEST_SET + file, 'r')\n",
    "        for line in f:\n",
    "            line = line.decode(\"ascii\",\"ignore\")\n",
    "            # document should always contain only one line\n",
    "            test_set.append(line)\n",
    "\n",
    "print('***** File Name Mapping *****')           \n",
    "for k, v in file_name_mapping.items():\n",
    "    print('{}: \"{}\"'.format(k, v))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### -------------------------- Text Preprocessing ---------------------------------------------------------------------------------------------------------------------"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "def text_preprocessing(test_set):\n",
    "    prepared_test_set = list()\n",
    "    for document in test_set:\n",
    "        \n",
    "        # tokenization – process of converting a text into tokens\n",
    "        tokens = word_tokenize(document)\n",
    "        \n",
    "        # remove stop-words\n",
    "        filtered_doc_words = [word for word in tokens if word not in stopwords.words('english')]\n",
    "        \n",
    "        # lemmatization process - procedure of obtaining the root form of the word\n",
    "        wordnet_lemmatizer = WordNetLemmatizer()\n",
    "        lemmatization_words = []\n",
    "        for word in filtered_doc_words:\n",
    "            lemm_word = wordnet_lemmatizer.lemmatize(word)\n",
    "            lemmatization_words.append(lemm_word)\n",
    "        \n",
    "        prepared_doc = ' '.join(lemmatization_words)\n",
    "        prepared_test_set.append(prepared_doc)\n",
    "        \n",
    "    return prepared_test_set\n",
    "\n",
    "prepared_test_set = text_preprocessing(test_set)    "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### -------------------------- KeyWords extraction ----------------------------------------------------------------------------"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "number_keywords = 10\n",
    "keywords_test_set = {}\n",
    "index = 0\n",
    "\n",
    "for doc in prepared_test_set:\n",
    "    extracted_keywords =  keywords(doc, words=number_keywords, scores=True, lemmatize=True)\n",
    "    keywords_test_set[index] = extracted_keywords\n",
    "    index += 1\n",
    "\n",
    "dataframe = list()  \n",
    "for value in keywords_test_set.values():\n",
    "    dataframe.append(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>KeyWord &amp; Score</th>\n",
       "      <th>KeyWord &amp; Score</th>\n",
       "      <th>KeyWord &amp; Score</th>\n",
       "      <th>KeyWord &amp; Score</th>\n",
       "      <th>KeyWord &amp; Score</th>\n",
       "      <th>KeyWord &amp; Score</th>\n",
       "      <th>KeyWord &amp; Score</th>\n",
       "      <th>KeyWord &amp; Score</th>\n",
       "      <th>KeyWord &amp; Score</th>\n",
       "      <th>KeyWord &amp; Score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>(study, [0.318763258672])</td>\n",
       "      <td>(adhd, [0.288811247658])</td>\n",
       "      <td>(pregnancy, [0.271242939913])</td>\n",
       "      <td>(risk, [0.264390659747])</td>\n",
       "      <td>(acetaminophen, [0.224141572013])</td>\n",
       "      <td>(attention, [0.170819185708])</td>\n",
       "      <td>(use, [0.165406795656])</td>\n",
       "      <td>(offspring, [0.139080819912])</td>\n",
       "      <td>(infection, [0.137813464181])</td>\n",
       "      <td>(outcome, [0.136368161902])</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>(costs, [0.3320741284])</td>\n",
       "      <td>(care, [0.276727789845])</td>\n",
       "      <td>(depression, [0.25152355147])</td>\n",
       "      <td>(effective, [0.246144203219])</td>\n",
       "      <td>(adolescents, [0.245083075426])</td>\n",
       "      <td>(health, [0.224768702332])</td>\n",
       "      <td>(intervention, [0.20406019158])</td>\n",
       "      <td>(group, [0.173564242552])</td>\n",
       "      <td>(qalys, [0.14849737834])</td>\n",
       "      <td>(collaborative, [0.146138270538])</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>(disorder, [0.400835511967])</td>\n",
       "      <td>(suicide, [0.328866517918])</td>\n",
       "      <td>(inpatient, [0.244975362963])</td>\n",
       "      <td>(cohort, [0.22359309293])</td>\n",
       "      <td>(adult, [0.215556334549])</td>\n",
       "      <td>(year, [0.211287295335])</td>\n",
       "      <td>(discharge, [0.177299101596])</td>\n",
       "      <td>(diagnosis, [0.155841064908])</td>\n",
       "      <td>(hospital, [0.153777114842])</td>\n",
       "      <td>(death, [0.143028922545])</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>(user, [0.267216429183])</td>\n",
       "      <td>(contraceptive, [0.257075094941])</td>\n",
       "      <td>(use, [0.245066868162])</td>\n",
       "      <td>(woman, [0.212146079792])</td>\n",
       "      <td>(associated, [0.177051729335])</td>\n",
       "      <td>(psychiatric, [0.169170011267])</td>\n",
       "      <td>(diagnosis, [0.168346994999])</td>\n",
       "      <td>(hormonal, [0.163656483025])</td>\n",
       "      <td>(january, [0.144412153096])</td>\n",
       "      <td>(year, [0.141149162559])</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>(avoidance, [0.33637819377])</td>\n",
       "      <td>(opioid, [0.260168854614])</td>\n",
       "      <td>(behavioral, [0.250658044231])</td>\n",
       "      <td>(task, [0.183852159204])</td>\n",
       "      <td>(hiding, [0.171616781522])</td>\n",
       "      <td>(different, [0.170747799566])</td>\n",
       "      <td>(dependence, [0.163464685072])</td>\n",
       "      <td>(abnormal, [0.146285660347])</td>\n",
       "      <td>(aversive event, [0.14605990018])</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>(clozapine, [0.299238648487])</td>\n",
       "      <td>(antipsychotic, [0.270985047024])</td>\n",
       "      <td>(effective, [0.249449074991])</td>\n",
       "      <td>(treatment, [0.234353855335])</td>\n",
       "      <td>(trials, [0.195890011285])</td>\n",
       "      <td>(schizophrenia, [0.193089950974])</td>\n",
       "      <td>(evidence, [0.155805473829])</td>\n",
       "      <td>(rcts, [0.155587895934])</td>\n",
       "      <td>(randomized, [0.147880608834])</td>\n",
       "      <td>(change, [0.146491841048])</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>(smoking, [0.325133307891])</td>\n",
       "      <td>(year, [0.241450876136])</td>\n",
       "      <td>(attacks, [0.185775123445])</td>\n",
       "      <td>(onset, [0.184524269285])</td>\n",
       "      <td>(risk, [0.183135987694])</td>\n",
       "      <td>(data, [0.175294298524])</td>\n",
       "      <td>(wave, [0.167876710833])</td>\n",
       "      <td>(panic, [0.158807946924])</td>\n",
       "      <td>(based, [0.15588890665])</td>\n",
       "      <td>(united, [0.155520409927])</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>(control, [0.234662902125])</td>\n",
       "      <td>(smi, [0.224329601417])</td>\n",
       "      <td>(medication, [0.166859435553])</td>\n",
       "      <td>(class, [0.166206461617])</td>\n",
       "      <td>(group, [0.166202166359])</td>\n",
       "      <td>(treatment, [0.164366642275])</td>\n",
       "      <td>(effective, [0.16394636219])</td>\n",
       "      <td>(interventions, [0.161796517003])</td>\n",
       "      <td>(knowledge, [0.158982657108])</td>\n",
       "      <td>(counseling, [0.157518926393])</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>(preferences, [0.422235830408])</td>\n",
       "      <td>(patients, [0.370151609122])</td>\n",
       "      <td>(treatment, [0.331900856392])</td>\n",
       "      <td>(outcome, [0.251996545759])</td>\n",
       "      <td>(psychotherapy, [0.232550057254])</td>\n",
       "      <td>(ptsd, [0.196338779899])</td>\n",
       "      <td>(depressed, [0.146501862787])</td>\n",
       "      <td>(clinical, [0.138754563027])</td>\n",
       "      <td>(research, [0.131335451141])</td>\n",
       "      <td>(chronic, [0.123320049096])</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>(cocaine, [0.371003971018])</td>\n",
       "      <td>(group, [0.313540014415])</td>\n",
       "      <td>(topiramate, [0.283979155483])</td>\n",
       "      <td>(subject, [0.251905802251])</td>\n",
       "      <td>(studied, [0.248619372311])</td>\n",
       "      <td>(use, [0.216307526629])</td>\n",
       "      <td>(treatment, [0.203472372092])</td>\n",
       "      <td>(placebo, [0.140252119317])</td>\n",
       "      <td>(week, [0.13265122596])</td>\n",
       "      <td>(control, [0.129466380513])</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                   KeyWord & Score                    KeyWord & Score  \\\n",
       "0        (study, [0.318763258672])           (adhd, [0.288811247658])   \n",
       "1          (costs, [0.3320741284])           (care, [0.276727789845])   \n",
       "2     (disorder, [0.400835511967])        (suicide, [0.328866517918])   \n",
       "3         (user, [0.267216429183])  (contraceptive, [0.257075094941])   \n",
       "4     (avoidance, [0.33637819377])         (opioid, [0.260168854614])   \n",
       "5    (clozapine, [0.299238648487])  (antipsychotic, [0.270985047024])   \n",
       "6      (smoking, [0.325133307891])           (year, [0.241450876136])   \n",
       "7      (control, [0.234662902125])            (smi, [0.224329601417])   \n",
       "8  (preferences, [0.422235830408])       (patients, [0.370151609122])   \n",
       "9      (cocaine, [0.371003971018])          (group, [0.313540014415])   \n",
       "\n",
       "                  KeyWord & Score                KeyWord & Score  \\\n",
       "0   (pregnancy, [0.271242939913])       (risk, [0.264390659747])   \n",
       "1   (depression, [0.25152355147])  (effective, [0.246144203219])   \n",
       "2   (inpatient, [0.244975362963])      (cohort, [0.22359309293])   \n",
       "3         (use, [0.245066868162])      (woman, [0.212146079792])   \n",
       "4  (behavioral, [0.250658044231])       (task, [0.183852159204])   \n",
       "5   (effective, [0.249449074991])  (treatment, [0.234353855335])   \n",
       "6     (attacks, [0.185775123445])      (onset, [0.184524269285])   \n",
       "7  (medication, [0.166859435553])      (class, [0.166206461617])   \n",
       "8   (treatment, [0.331900856392])    (outcome, [0.251996545759])   \n",
       "9  (topiramate, [0.283979155483])    (subject, [0.251905802251])   \n",
       "\n",
       "                     KeyWord & Score                    KeyWord & Score  \\\n",
       "0  (acetaminophen, [0.224141572013])      (attention, [0.170819185708])   \n",
       "1    (adolescents, [0.245083075426])         (health, [0.224768702332])   \n",
       "2          (adult, [0.215556334549])           (year, [0.211287295335])   \n",
       "3     (associated, [0.177051729335])    (psychiatric, [0.169170011267])   \n",
       "4         (hiding, [0.171616781522])      (different, [0.170747799566])   \n",
       "5         (trials, [0.195890011285])  (schizophrenia, [0.193089950974])   \n",
       "6           (risk, [0.183135987694])           (data, [0.175294298524])   \n",
       "7          (group, [0.166202166359])      (treatment, [0.164366642275])   \n",
       "8  (psychotherapy, [0.232550057254])           (ptsd, [0.196338779899])   \n",
       "9        (studied, [0.248619372311])            (use, [0.216307526629])   \n",
       "\n",
       "                   KeyWord & Score                    KeyWord & Score  \\\n",
       "0          (use, [0.165406795656])      (offspring, [0.139080819912])   \n",
       "1  (intervention, [0.20406019158])          (group, [0.173564242552])   \n",
       "2    (discharge, [0.177299101596])      (diagnosis, [0.155841064908])   \n",
       "3    (diagnosis, [0.168346994999])       (hormonal, [0.163656483025])   \n",
       "4   (dependence, [0.163464685072])       (abnormal, [0.146285660347])   \n",
       "5     (evidence, [0.155805473829])           (rcts, [0.155587895934])   \n",
       "6         (wave, [0.167876710833])          (panic, [0.158807946924])   \n",
       "7     (effective, [0.16394636219])  (interventions, [0.161796517003])   \n",
       "8    (depressed, [0.146501862787])       (clinical, [0.138754563027])   \n",
       "9    (treatment, [0.203472372092])        (placebo, [0.140252119317])   \n",
       "\n",
       "                     KeyWord & Score                    KeyWord & Score  \n",
       "0      (infection, [0.137813464181])        (outcome, [0.136368161902])  \n",
       "1           (qalys, [0.14849737834])  (collaborative, [0.146138270538])  \n",
       "2       (hospital, [0.153777114842])          (death, [0.143028922545])  \n",
       "3        (january, [0.144412153096])           (year, [0.141149162559])  \n",
       "4  (aversive event, [0.14605990018])                               None  \n",
       "5     (randomized, [0.147880608834])         (change, [0.146491841048])  \n",
       "6           (based, [0.15588890665])         (united, [0.155520409927])  \n",
       "7      (knowledge, [0.158982657108])     (counseling, [0.157518926393])  \n",
       "8       (research, [0.131335451141])        (chronic, [0.123320049096])  \n",
       "9            (week, [0.13265122596])        (control, [0.129466380513])  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "KEYWORDS = pd.DataFrame(dataframe, columns=['KeyWord & Score']*10)\n",
    "KEYWORDS"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### -------------------------- Syntactic Parsing. Part of speech tagging. ---------------------------------------------------------------------------------------\n",
    "\n",
    "Universal Part-of-Speech Tagset:\n",
    "\n",
    "CC: conjunction, coordinating\n",
    "\n",
    "CD: numeral, cardinal\n",
    "\n",
    "DT: determiner\n",
    "\n",
    "IN: preposition or conjunction, subordinating\n",
    "\n",
    "JJ: adjective or numeral, ordinal\n",
    "\n",
    "JJR: adjective, comparative\n",
    "\n",
    "JJS: adjective, superlative\n",
    "\n",
    "LS: list item marker\n",
    "\n",
    "MD: modal auxiliary\n",
    "\n",
    "NN: noun, common, singular or mass\n",
    "\n",
    "NNP: noun, proper, singular\n",
    "\n",
    "NNS: noun, common, plural\n",
    "\n",
    "PDT: pre-determiner\n",
    "\n",
    "POS: genitive marker\n",
    "\n",
    "PRP: pronoun, personal\n",
    "\n",
    "RB: adverb\n",
    "\n",
    "RBR: adverb, comparative\n",
    "\n",
    "RBS: adverb, superlative\n",
    "\n",
    "RP: particle\n",
    "\n",
    "UH: interjection\n",
    "\n",
    "VB: verb, base form\n",
    "\n",
    "VBD: verb, past tense\n",
    "\n",
    "VBG: verb, present participle or gerund\n",
    "\n",
    "VBN: verb, past participle\n",
    "\n",
    "VBP: verb, present tense, not 3rd person singular\n",
    "\n",
    "VBZ: verb, present tense, 3rd person singular\n",
    "\n",
    "WDT: WH-determiner\n",
    "\n",
    "WP: WH-pronoun\n",
    "\n",
    "WRB: Wh-adverb"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[(u'Association', 'NNP'),\n",
       " (u'Hormonal', 'NNP'),\n",
       " (u'Contraception', 'NNP'),\n",
       " (u'With', 'IN'),\n",
       " (u'Depression', 'NNP'),\n",
       " (u'.', '.'),\n",
       " (u'Is', 'VBZ'),\n",
       " (u'use', 'JJ'),\n",
       " (u'hormonal', 'JJ'),\n",
       " (u'contraception', 'NN'),\n",
       " (u'associated', 'VBN'),\n",
       " (u'treatment', 'NN'),\n",
       " (u'depression', 'NN'),\n",
       " (u'?', '.'),\n",
       " (u'In', 'IN'),\n",
       " (u'nationwide', 'JJ'),\n",
       " (u'prospective', 'JJ'),\n",
       " (u'cohort', 'NN'),\n",
       " (u'study', 'VBD'),\n",
       " (u'1', 'CD'),\n",
       " (u'million', 'CD'),\n",
       " (u'woman', 'NN'),\n",
       " (u'living', 'VBG'),\n",
       " (u'Denmark', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'increased', 'VBD'),\n",
       " (u'risk', 'NN'),\n",
       " (u'first', 'RB'),\n",
       " (u'use', 'NN'),\n",
       " (u'antidepressant', 'JJ'),\n",
       " (u'first', 'JJ'),\n",
       " (u'diagnosis', 'NN'),\n",
       " (u'depression', 'NN'),\n",
       " (u'found', 'VBD'),\n",
       " (u'among', 'IN'),\n",
       " (u'user', 'JJ'),\n",
       " (u'different', 'JJ'),\n",
       " (u'type', 'NN'),\n",
       " (u'hormonal', 'JJ'),\n",
       " (u'contraception', 'NN'),\n",
       " (u',', ','),\n",
       " (u'highest', 'JJS'),\n",
       " (u'rate', 'NN'),\n",
       " (u'among', 'IN'),\n",
       " (u'adolescent', 'JJ'),\n",
       " (u'.', '.'),\n",
       " (u'Health', 'NNP'),\n",
       " (u'care', 'NN'),\n",
       " (u'professional', 'JJ'),\n",
       " (u'aware', 'NN'),\n",
       " (u'relatively', 'RB'),\n",
       " (u'hitherto', 'JJ'),\n",
       " (u'unnoticed', 'JJ'),\n",
       " (u'adverse', 'JJ'),\n",
       " (u'effect', 'NN'),\n",
       " (u'hormonal', 'JJ'),\n",
       " (u'contraception', 'NN'),\n",
       " (u'.', '.'),\n",
       " (u'Millions', 'NNP'),\n",
       " (u'woman', 'NN'),\n",
       " (u'worldwide', 'NN'),\n",
       " (u'use', 'IN'),\n",
       " (u'hormonal', 'JJ'),\n",
       " (u'contraception', 'NN'),\n",
       " (u'.', '.'),\n",
       " (u'Despite', 'IN'),\n",
       " (u'clinical', 'JJ'),\n",
       " (u'evidence', 'NN'),\n",
       " (u'influence', 'NN'),\n",
       " (u'hormonal', 'JJ'),\n",
       " (u'contraception', 'NN'),\n",
       " (u'woman', 'NN'),\n",
       " (u'mood', 'NN'),\n",
       " (u',', ','),\n",
       " (u'association', 'NN'),\n",
       " (u'use', 'NN'),\n",
       " (u'hormonal', 'JJ'),\n",
       " (u'contraception', 'NN'),\n",
       " (u'mood', 'NN'),\n",
       " (u'disturbance', 'NN'),\n",
       " (u'remain', 'VBP'),\n",
       " (u'inadequately', 'RB'),\n",
       " (u'addressed', 'VBN'),\n",
       " (u'.', '.'),\n",
       " (u'To', 'TO'),\n",
       " (u'investigate', 'VB'),\n",
       " (u'whether', 'IN'),\n",
       " (u'use', 'NN'),\n",
       " (u'hormonal', 'JJ'),\n",
       " (u'contraception', 'NN'),\n",
       " (u'positively', 'RB'),\n",
       " (u'associated', 'VBN'),\n",
       " (u'subsequent', 'JJ'),\n",
       " (u'use', 'NN'),\n",
       " (u'antidepressant', 'JJ'),\n",
       " (u'diagnosis', 'NN'),\n",
       " (u'depression', 'NN'),\n",
       " (u'psychiatric', 'JJ'),\n",
       " (u'hospital', 'NN'),\n",
       " (u'.', '.'),\n",
       " (u'This', 'DT'),\n",
       " (u'nationwide', 'JJ'),\n",
       " (u'prospective', 'JJ'),\n",
       " (u'cohort', 'NN'),\n",
       " (u'study', 'NN'),\n",
       " (u'combined', 'VBN'),\n",
       " (u'data', 'NNS'),\n",
       " (u'National', 'NNP'),\n",
       " (u'Prescription', 'NNP'),\n",
       " (u'Register', 'NNP'),\n",
       " (u'Psychiatric', 'NNP'),\n",
       " (u'Central', 'NNP'),\n",
       " (u'Research', 'NNP'),\n",
       " (u'Register', 'NNP'),\n",
       " (u'Denmark', 'NNP'),\n",
       " (u'.', '.'),\n",
       " (u'All', 'DT'),\n",
       " (u'woman', 'NN'),\n",
       " (u'adolescent', 'VBD'),\n",
       " (u'aged', 'VBD'),\n",
       " (u'15', 'CD'),\n",
       " (u'34', 'CD'),\n",
       " (u'year', 'NN'),\n",
       " (u'living', 'NN'),\n",
       " (u'Denmark', 'NNP'),\n",
       " (u'followed', 'VBD'),\n",
       " (u'January', 'NNP'),\n",
       " (u'1', 'CD'),\n",
       " (u',', ','),\n",
       " (u'2000', 'CD'),\n",
       " (u',', ','),\n",
       " (u'December', 'NNP'),\n",
       " (u'2013', 'CD'),\n",
       " (u',', ','),\n",
       " (u'prior', 'JJ'),\n",
       " (u'depression', 'NN'),\n",
       " (u'diagnosis', 'NN'),\n",
       " (u',', ','),\n",
       " (u'redeemed', 'VBN'),\n",
       " (u'prescription', 'NN'),\n",
       " (u'antidepressant', 'NN'),\n",
       " (u',', ','),\n",
       " (u'major', 'JJ'),\n",
       " (u'psychiatric', 'JJ'),\n",
       " (u'diagnosis', 'NN'),\n",
       " (u',', ','),\n",
       " (u'cancer', 'NN'),\n",
       " (u',', ','),\n",
       " (u'venous', 'JJ'),\n",
       " (u'thrombosis', 'NN'),\n",
       " (u',', ','),\n",
       " (u'infertility', 'NN'),\n",
       " (u'treatment', 'NN'),\n",
       " (u'.', '.'),\n",
       " (u'Data', 'NNP'),\n",
       " (u'collected', 'VBD'),\n",
       " (u'January', 'NNP'),\n",
       " (u'1', 'CD'),\n",
       " (u',', ','),\n",
       " (u'1995', 'CD'),\n",
       " (u',', ','),\n",
       " (u'December', 'NNP'),\n",
       " (u'31', 'CD'),\n",
       " (u',', ','),\n",
       " (u'2013', 'CD'),\n",
       " (u',', ','),\n",
       " (u'analyzed', 'VBD'),\n",
       " (u'January', 'NNP'),\n",
       " (u'1', 'CD'),\n",
       " (u',', ','),\n",
       " (u'2015', 'CD'),\n",
       " (u',', ','),\n",
       " (u'April', 'NNP'),\n",
       " (u'1', 'CD'),\n",
       " (u',', ','),\n",
       " (u'2016', 'CD'),\n",
       " (u'.', '.'),\n",
       " (u'Use', 'VB'),\n",
       " (u'different', 'JJ'),\n",
       " (u'type', 'JJ'),\n",
       " (u'hormonal', 'JJ'),\n",
       " (u'contraception', 'NN'),\n",
       " (u'.', '.'),\n",
       " (u'With', 'IN'),\n",
       " (u'time-varying', 'JJ'),\n",
       " (u'covariates', 'NNS'),\n",
       " (u',', ','),\n",
       " (u'adjusted', 'VBN'),\n",
       " (u'incidence', 'NN'),\n",
       " (u'rate', 'NN'),\n",
       " (u'ratio', 'NN'),\n",
       " (u'(', '('),\n",
       " (u'RRs', 'NNP'),\n",
       " (u')', ')'),\n",
       " (u'calculated', 'VBD'),\n",
       " (u'first', 'JJ'),\n",
       " (u'use', 'NN'),\n",
       " (u'antidepressant', 'NN'),\n",
       " (u'first', 'JJ'),\n",
       " (u'diagnosis', 'NN'),\n",
       " (u'depression', 'NN'),\n",
       " (u'psychiatric', 'JJ'),\n",
       " (u'hospital', 'NN'),\n",
       " (u'.', '.'),\n",
       " (u'A', 'DT'),\n",
       " (u'total', 'JJ'),\n",
       " (u'1061997', 'CD'),\n",
       " (u'woman', 'NN'),\n",
       " (u'(', '('),\n",
       " (u'mean', 'JJ'),\n",
       " (u'[', 'NNP'),\n",
       " (u'SD', 'NNP'),\n",
       " (u']', 'NNP'),\n",
       " (u'age', 'NN'),\n",
       " (u',', ','),\n",
       " (u'24.4', 'CD'),\n",
       " (u'[', 'NN'),\n",
       " (u'0.001', 'CD'),\n",
       " (u']', 'JJ'),\n",
       " (u'year', 'NN'),\n",
       " (u';', ':'),\n",
       " (u'mean', 'CC'),\n",
       " (u'[', 'NNP'),\n",
       " (u'SD', 'NNP'),\n",
       " (u']', 'NNP'),\n",
       " (u'follow-up', 'NN'),\n",
       " (u',', ','),\n",
       " (u'6.4', 'CD'),\n",
       " (u'[', 'NN'),\n",
       " (u'0.004', 'CD'),\n",
       " (u']', 'JJ'),\n",
       " (u'year', 'NN'),\n",
       " (u')', ')'),\n",
       " (u'included', 'VBD'),\n",
       " (u'analysis', 'NN'),\n",
       " (u'.', '.'),\n",
       " (u'Compared', 'NNP'),\n",
       " (u'nonusers', 'NNS'),\n",
       " (u',', ','),\n",
       " (u'user', 'NN'),\n",
       " (u'combined', 'VBD'),\n",
       " (u'oral', 'JJ'),\n",
       " (u'contraceptive', 'NN'),\n",
       " (u'RR', 'NNP'),\n",
       " (u'first', 'RB'),\n",
       " (u'use', 'VBP'),\n",
       " (u'antidepressant', 'JJ'),\n",
       " (u'1.23', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.22-1.25', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u'.', '.'),\n",
       " (u'Users', 'NNS'),\n",
       " (u'progestogen-only', 'RB'),\n",
       " (u'pill', 'NN'),\n",
       " (u'RR', 'NNP'),\n",
       " (u'first', 'RB'),\n",
       " (u'use', 'VBP'),\n",
       " (u'antidepressant', 'JJ'),\n",
       " (u'1.34', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.27-1.40', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u';', ':'),\n",
       " (u'user', 'JJ'),\n",
       " (u'patch', 'NN'),\n",
       " (u'(', '('),\n",
       " (u'norgestrolmin', 'NN'),\n",
       " (u')', ')'),\n",
       " (u',', ','),\n",
       " (u'2.0', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.76-2.18', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u';', ':'),\n",
       " (u'user', 'JJ'),\n",
       " (u'vaginal', 'JJ'),\n",
       " (u'ring', 'NN'),\n",
       " (u'(', '('),\n",
       " (u'etonogestrel', 'NN'),\n",
       " (u')', ')'),\n",
       " (u',', ','),\n",
       " (u'1.6', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.55-1.69', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u';', ':'),\n",
       " (u'user', 'JJ'),\n",
       " (u'levonorgestrel', 'NN'),\n",
       " (u'intrauterine', 'NN'),\n",
       " (u'system', 'NN'),\n",
       " (u',', ','),\n",
       " (u'1.4', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.31-1.42', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u'.', '.'),\n",
       " (u'For', 'IN'),\n",
       " (u'depression', 'NN'),\n",
       " (u'diagnosis', 'NN'),\n",
       " (u',', ','),\n",
       " (u'similar', 'JJ'),\n",
       " (u'slightly', 'RB'),\n",
       " (u'lower', 'JJR'),\n",
       " (u'estimate', 'NN'),\n",
       " (u'found', 'VBD'),\n",
       " (u'.', '.'),\n",
       " (u'The', 'DT'),\n",
       " (u'relative', 'JJ'),\n",
       " (u'risk', 'NN'),\n",
       " (u'generally', 'RB'),\n",
       " (u'decreased', 'VBD'),\n",
       " (u'increasing', 'VBG'),\n",
       " (u'age', 'NN'),\n",
       " (u'.', '.'),\n",
       " (u'Adolescents', 'NNS'),\n",
       " (u'(', '('),\n",
       " (u'age', 'NN'),\n",
       " (u'range', 'NN'),\n",
       " (u',', ','),\n",
       " (u'15-19', 'JJ'),\n",
       " (u'year', 'NN'),\n",
       " (u')', ')'),\n",
       " (u'using', 'VBG'),\n",
       " (u'combined', 'VBN'),\n",
       " (u'oral', 'JJ'),\n",
       " (u'contraceptive', 'NN'),\n",
       " (u'RR', 'NNP'),\n",
       " (u'first', 'RB'),\n",
       " (u'use', 'VBP'),\n",
       " (u'antidepressant', 'JJ'),\n",
       " (u'1.8', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.75-1.84', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u'using', 'VBG'),\n",
       " (u'progestin-only', 'JJ'),\n",
       " (u'pill', 'NN'),\n",
       " (u',', ','),\n",
       " (u'2.2', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.99-2.52', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u'.', '.'),\n",
       " (u'Six', 'NNP'),\n",
       " (u'month', 'NN'),\n",
       " (u'starting', 'VBG'),\n",
       " (u'use', 'JJ'),\n",
       " (u'hormonal', 'JJ'),\n",
       " (u'contraceptive', 'NN'),\n",
       " (u',', ','),\n",
       " (u'RR', 'NNP'),\n",
       " (u'antidepressant', 'NN'),\n",
       " (u'use', 'NN'),\n",
       " (u'peaked', 'VBD'),\n",
       " (u'1.4', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.34-1.46', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u'.', '.'),\n",
       " (u'When', 'WRB'),\n",
       " (u'reference', 'NN'),\n",
       " (u'group', 'NN'),\n",
       " (u'changed', 'VBD'),\n",
       " (u'never', 'RB'),\n",
       " (u'used', 'VBN'),\n",
       " (u'hormonal', 'JJ'),\n",
       " (u'contraception', 'NN'),\n",
       " (u',', ','),\n",
       " (u'RR', 'NNP'),\n",
       " (u'estimate', 'VBP'),\n",
       " (u'user', 'NN'),\n",
       " (u'combined', 'VBN'),\n",
       " (u'oral', 'JJ'),\n",
       " (u'contraceptive', 'NN'),\n",
       " (u'increased', 'VBD'),\n",
       " (u'1.7', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.66-1.71', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u'.', '.'),\n",
       " (u'A', 'DT'),\n",
       " (u'total', 'JJ'),\n",
       " (u'1061997', 'CD'),\n",
       " (u'woman', 'NN'),\n",
       " (u'(', '('),\n",
       " (u'mean', 'JJ'),\n",
       " (u'[', 'NNP'),\n",
       " (u'SD', 'NNP'),\n",
       " (u']', 'NNP'),\n",
       " (u'age', 'NN'),\n",
       " (u',', ','),\n",
       " (u'24.4', 'CD'),\n",
       " (u'[', 'NN'),\n",
       " (u'0.001', 'CD'),\n",
       " (u']', 'JJ'),\n",
       " (u'year', 'NN'),\n",
       " (u';', ':'),\n",
       " (u'mean', 'CC'),\n",
       " (u'[', 'NNP'),\n",
       " (u'SD', 'NNP'),\n",
       " (u']', 'NNP'),\n",
       " (u'follow-up', 'NN'),\n",
       " (u',', ','),\n",
       " (u'6.4', 'CD'),\n",
       " (u'[', 'NN'),\n",
       " (u'0.004', 'CD'),\n",
       " (u']', 'JJ'),\n",
       " (u'year', 'NN'),\n",
       " (u')', ')'),\n",
       " (u'included', 'VBD'),\n",
       " (u'analysis', 'NN'),\n",
       " (u'.', '.'),\n",
       " (u'Compared', 'NNP'),\n",
       " (u'nonusers', 'NNS'),\n",
       " (u',', ','),\n",
       " (u'user', 'NN'),\n",
       " (u'combined', 'VBD'),\n",
       " (u'oral', 'JJ'),\n",
       " (u'contraceptive', 'NN'),\n",
       " (u'RR', 'NNP'),\n",
       " (u'first', 'RB'),\n",
       " (u'use', 'VBP'),\n",
       " (u'antidepressant', 'JJ'),\n",
       " (u'1.23', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.22-1.25', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u'.', '.'),\n",
       " (u'Users', 'NNS'),\n",
       " (u'progestogen-only', 'RB'),\n",
       " (u'pill', 'NN'),\n",
       " (u'RR', 'NNP'),\n",
       " (u'first', 'RB'),\n",
       " (u'use', 'VBP'),\n",
       " (u'antidepressant', 'JJ'),\n",
       " (u'1.34', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.27-1.40', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u';', ':'),\n",
       " (u'user', 'JJ'),\n",
       " (u'patch', 'NN'),\n",
       " (u'(', '('),\n",
       " (u'norgestrolmin', 'NN'),\n",
       " (u')', ')'),\n",
       " (u',', ','),\n",
       " (u'2.0', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.76-2.18', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u';', ':'),\n",
       " (u'user', 'JJ'),\n",
       " (u'vaginal', 'JJ'),\n",
       " (u'ring', 'NN'),\n",
       " (u'(', '('),\n",
       " (u'etonogestrel', 'NN'),\n",
       " (u')', ')'),\n",
       " (u',', ','),\n",
       " (u'1.6', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.55-1.69', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u';', ':'),\n",
       " (u'user', 'JJ'),\n",
       " (u'levonorgestrel', 'NN'),\n",
       " (u'intrauterine', 'NN'),\n",
       " (u'system', 'NN'),\n",
       " (u',', ','),\n",
       " (u'1.4', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.31-1.42', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u'.', '.'),\n",
       " (u'For', 'IN'),\n",
       " (u'depression', 'NN'),\n",
       " (u'diagnosis', 'NN'),\n",
       " (u',', ','),\n",
       " (u'similar', 'JJ'),\n",
       " (u'slightly', 'RB'),\n",
       " (u'lower', 'JJR'),\n",
       " (u'estimate', 'NN'),\n",
       " (u'found', 'VBD'),\n",
       " (u'.', '.'),\n",
       " (u'The', 'DT'),\n",
       " (u'relative', 'JJ'),\n",
       " (u'risk', 'NN'),\n",
       " (u'generally', 'RB'),\n",
       " (u'decreased', 'VBD'),\n",
       " (u'increasing', 'VBG'),\n",
       " (u'age', 'NN'),\n",
       " (u'.', '.'),\n",
       " (u'Adolescents', 'NNS'),\n",
       " (u'(', '('),\n",
       " (u'age', 'NN'),\n",
       " (u'range', 'NN'),\n",
       " (u',', ','),\n",
       " (u'15-19', 'JJ'),\n",
       " (u'year', 'NN'),\n",
       " (u')', ')'),\n",
       " (u'using', 'VBG'),\n",
       " (u'combined', 'VBN'),\n",
       " (u'oral', 'JJ'),\n",
       " (u'contraceptive', 'NN'),\n",
       " (u'RR', 'NNP'),\n",
       " (u'first', 'RB'),\n",
       " (u'use', 'VBP'),\n",
       " (u'antidepressant', 'JJ'),\n",
       " (u'1.8', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.75-1.84', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u'using', 'VBG'),\n",
       " (u'progestin-only', 'JJ'),\n",
       " (u'pill', 'NN'),\n",
       " (u',', ','),\n",
       " (u'2.2', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.99-2.52', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u'.', '.'),\n",
       " (u'Six', 'NNP'),\n",
       " (u'month', 'NN'),\n",
       " (u'starting', 'VBG'),\n",
       " (u'use', 'JJ'),\n",
       " (u'hormonal', 'JJ'),\n",
       " (u'contraceptive', 'NN'),\n",
       " (u',', ','),\n",
       " (u'RR', 'NNP'),\n",
       " (u'antidepressant', 'NN'),\n",
       " (u'use', 'NN'),\n",
       " (u'peaked', 'VBD'),\n",
       " (u'1.4', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.34-1.46', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u'.', '.'),\n",
       " (u'When', 'WRB'),\n",
       " (u'reference', 'NN'),\n",
       " (u'group', 'NN'),\n",
       " (u'changed', 'VBD'),\n",
       " (u'never', 'RB'),\n",
       " (u'used', 'VBN'),\n",
       " (u'hormonal', 'JJ'),\n",
       " (u'contraception', 'NN'),\n",
       " (u',', ','),\n",
       " (u'RR', 'NNP'),\n",
       " (u'estimate', 'VBP'),\n",
       " (u'user', 'NN'),\n",
       " (u'combined', 'VBN'),\n",
       " (u'oral', 'JJ'),\n",
       " (u'contraceptive', 'NN'),\n",
       " (u'increased', 'VBD'),\n",
       " (u'1.7', 'CD'),\n",
       " (u'(', '('),\n",
       " (u'95', 'CD'),\n",
       " (u'%', 'NN'),\n",
       " (u'CI', 'NNP'),\n",
       " (u',', ','),\n",
       " (u'1.66-1.71', 'JJ'),\n",
       " (u')', ')'),\n",
       " (u'.', '.')]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "partofspeech_tagging_all = list()\n",
    "for doc in prepared_test_set:\n",
    "    tokens = word_tokenize(doc)\n",
    "    partofspeech_tagging_doc = pos_tag(tokens)\n",
    "    partofspeech_tagging_all.append(partofspeech_tagging_doc)\n",
    "\n",
    "# for example, to print tagged text, for '3' article\n",
    "partofspeech_tagging_all[3]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### -------------------------- Word Embedding (text vectors). Word2Vec Model. ---------------------"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "tsne = TSNE(n_components=2, random_state=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "input2model = list ()\n",
    "for doc in dataframe:\n",
    "    words_doc_list = []\n",
    "    for word in doc:\n",
    "        words_doc_list.append(word[0])\n",
    "    input2model.append(words_doc_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "WARNING:gensim.models.word2vec:under 10 jobs per worker: consider setting a smaller `batch_words' for smoother alpha decay\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "(84L, 100L)"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# train the model on your corpus  \n",
    "model = Word2Vec(input2model, min_count = 1, workers=4)\n",
    "model_keys = model.vocab.keys()\n",
    "\n",
    "model_values = []\n",
    "for key in model_keys:\n",
    "    model_values.append(model[key])\n",
    "\n",
    "model_values = np.array(model_values)\n",
    "model_values.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\kvoronaya\\AppData\\Local\\Continuum\\Anaconda2\\lib\\site-packages\\matplotlib\\collections.py:590: FutureWarning: elementwise comparison failed; returning scalar instead, but in the future will perform elementwise comparison\n",
      "  if self._edgecolors == str('face'):\n"
     ]
    }
   ],
   "source": [
    "reduced_matrix = tsne.fit_transform(model_values)\n",
    "\n",
    "pyl.figure(figsize=(200, 200), dpi=100)\n",
    "max_x = np.amax(reduced_matrix, axis=0)[0]\n",
    "max_y = np.amax(reduced_matrix, axis=0)[1]\n",
    "pyl.xlim((-max_x,max_x))\n",
    "pyl.ylim((-max_y,max_y))\n",
    "\n",
    "pyl.scatter(reduced_matrix[:, 0], reduced_matrix[:, 1], 20)\n",
    "\n",
    "for w in range(0, len(model_keys)):\n",
    "    target_word = model_keys[w]\n",
    "    x = reduced_matrix[w, 0]\n",
    "    y = reduced_matrix[w, 1]\n",
    "    pyl.annotate(target_word, (x,y))\n",
    "    \n",
    "pyl.title('Word2Vec Model')\n",
    "pyl.grid()\n",
    "pyl.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### -------------------------- TF – IDF matrices and Search cosine similarity between documents ---------------------"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "# remove morphological affixes from words, leaving only the word stem\n",
    "stemmer = nltk.stem.porter.PorterStemmer()\n",
    "\n",
    "def stem_tokens(tokens, stemmer):\n",
    "    stemmed = []\n",
    "    for item in tokens:\n",
    "        stemmed.append(stemmer.stem(item))\n",
    "    return stemmed\n",
    "\n",
    "def tokenize(text):\n",
    "    tokens = nltk.word_tokenize(text)\n",
    "    tokens = [i for i in tokens if i not in string.punctuation]\n",
    "    stems = stem_tokens(tokens, stemmer)\n",
    "    return stems\n",
    "\n",
    "# TF-IDF matrix for corpus \n",
    "corpus_tfidf = TfidfVectorizer(stop_words='english', tokenizer=tokenize)\n",
    "corpus_representation = corpus_tfidf.fit_transform(prepared_test_set)\n",
    "\n",
    "feature = corpus_tfidf.get_feature_names()\n",
    "\n",
    "corpus_representation_arr = corpus_representation.toarray()\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>0</th>\n",
       "      <th>1</th>\n",
       "      <th>2</th>\n",
       "      <th>3</th>\n",
       "      <th>4</th>\n",
       "      <th>5</th>\n",
       "      <th>6</th>\n",
       "      <th>7</th>\n",
       "      <th>8</th>\n",
       "      <th>9</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.023949</td>\n",
       "      <td>0.087947</td>\n",
       "      <td>0.058019</td>\n",
       "      <td>0.059277</td>\n",
       "      <td>0.042445</td>\n",
       "      <td>0.069383</td>\n",
       "      <td>0.027360</td>\n",
       "      <td>0.034432</td>\n",
       "      <td>0.043167</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0.023949</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.105139</td>\n",
       "      <td>0.180694</td>\n",
       "      <td>0.031528</td>\n",
       "      <td>0.105794</td>\n",
       "      <td>0.063669</td>\n",
       "      <td>0.218488</td>\n",
       "      <td>0.056997</td>\n",
       "      <td>0.074725</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>0.087947</td>\n",
       "      <td>0.105139</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.132950</td>\n",
       "      <td>0.026008</td>\n",
       "      <td>0.057755</td>\n",
       "      <td>0.074677</td>\n",
       "      <td>0.038655</td>\n",
       "      <td>0.048437</td>\n",
       "      <td>0.023775</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0.058019</td>\n",
       "      <td>0.180694</td>\n",
       "      <td>0.132950</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.022881</td>\n",
       "      <td>0.056621</td>\n",
       "      <td>0.113921</td>\n",
       "      <td>0.034089</td>\n",
       "      <td>0.022842</td>\n",
       "      <td>0.050035</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0.059277</td>\n",
       "      <td>0.031528</td>\n",
       "      <td>0.026008</td>\n",
       "      <td>0.022881</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.039640</td>\n",
       "      <td>0.037672</td>\n",
       "      <td>0.132686</td>\n",
       "      <td>0.055159</td>\n",
       "      <td>0.081207</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>0.042445</td>\n",
       "      <td>0.105794</td>\n",
       "      <td>0.057755</td>\n",
       "      <td>0.056621</td>\n",
       "      <td>0.039640</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.028964</td>\n",
       "      <td>0.160558</td>\n",
       "      <td>0.089039</td>\n",
       "      <td>0.089960</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>0.069383</td>\n",
       "      <td>0.063669</td>\n",
       "      <td>0.074677</td>\n",
       "      <td>0.113921</td>\n",
       "      <td>0.037672</td>\n",
       "      <td>0.028964</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.026610</td>\n",
       "      <td>0.007189</td>\n",
       "      <td>0.041659</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>0.027360</td>\n",
       "      <td>0.218488</td>\n",
       "      <td>0.038655</td>\n",
       "      <td>0.034089</td>\n",
       "      <td>0.132686</td>\n",
       "      <td>0.160558</td>\n",
       "      <td>0.026610</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.098097</td>\n",
       "      <td>0.124270</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>0.034432</td>\n",
       "      <td>0.056997</td>\n",
       "      <td>0.048437</td>\n",
       "      <td>0.022842</td>\n",
       "      <td>0.055159</td>\n",
       "      <td>0.089039</td>\n",
       "      <td>0.007189</td>\n",
       "      <td>0.098097</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.076625</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>0.043167</td>\n",
       "      <td>0.074725</td>\n",
       "      <td>0.023775</td>\n",
       "      <td>0.050035</td>\n",
       "      <td>0.081207</td>\n",
       "      <td>0.089960</td>\n",
       "      <td>0.041659</td>\n",
       "      <td>0.124270</td>\n",
       "      <td>0.076625</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          0         1         2         3         4         5         6  \\\n",
       "0  1.000000  0.023949  0.087947  0.058019  0.059277  0.042445  0.069383   \n",
       "1  0.023949  1.000000  0.105139  0.180694  0.031528  0.105794  0.063669   \n",
       "2  0.087947  0.105139  1.000000  0.132950  0.026008  0.057755  0.074677   \n",
       "3  0.058019  0.180694  0.132950  1.000000  0.022881  0.056621  0.113921   \n",
       "4  0.059277  0.031528  0.026008  0.022881  1.000000  0.039640  0.037672   \n",
       "5  0.042445  0.105794  0.057755  0.056621  0.039640  1.000000  0.028964   \n",
       "6  0.069383  0.063669  0.074677  0.113921  0.037672  0.028964  1.000000   \n",
       "7  0.027360  0.218488  0.038655  0.034089  0.132686  0.160558  0.026610   \n",
       "8  0.034432  0.056997  0.048437  0.022842  0.055159  0.089039  0.007189   \n",
       "9  0.043167  0.074725  0.023775  0.050035  0.081207  0.089960  0.041659   \n",
       "\n",
       "          7         8         9  \n",
       "0  0.027360  0.034432  0.043167  \n",
       "1  0.218488  0.056997  0.074725  \n",
       "2  0.038655  0.048437  0.023775  \n",
       "3  0.034089  0.022842  0.050035  \n",
       "4  0.132686  0.055159  0.081207  \n",
       "5  0.160558  0.089039  0.089960  \n",
       "6  0.026610  0.007189  0.041659  \n",
       "7  1.000000  0.098097  0.124270  \n",
       "8  0.098097  1.000000  0.076625  \n",
       "9  0.124270  0.076625  1.000000  "
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def cosine_similarity_results(query_doc):\n",
    "    tfidf_query_doc = corpus_tfidf.transform([query_doc])\n",
    "    tfidf_query_doc = tfidf_query_doc.toarray()\n",
    "    row_i = []\n",
    "    for i in xrange(len(prepared_test_set)):\n",
    "        cosine_dist = cosine_similarity(\n",
    "            corpus_representation_arr[i].reshape(1,-1), tfidf_query_doc.reshape(1,-1))\n",
    "        row_i.append(cosine_dist[0][0])\n",
    "\n",
    "    cosine_sim_data.append(row_i)\n",
    "\n",
    "    \n",
    "cosine_sim_data = list()    \n",
    "for doc in prepared_test_set:\n",
    "    cosine_similarity_results(doc)\n",
    "    \n",
    "    \n",
    "cosine_sim_data = pd.DataFrame(cosine_sim_data)\n",
    "cosine_sim_data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "reduced_tfidf_matr = tsne.fit_transform(corpus_representation_arr)\n",
    "\n",
    "labels = list()\n",
    "for i in xrange(len(prepared_test_set)):\n",
    "    target_label = 'doc.#{}'.format(i)\n",
    "    labels.append(target_label)\n",
    "\n",
    "    \n",
    "pyl.figure(figsize=(200, 200), dpi=100)\n",
    "max_x = np.amax(reduced_tfidf_matr, axis=0)[0]\n",
    "max_y = np.amax(reduced_tfidf_matr, axis=0)[1]\n",
    "pyl.xlim((-max_x,max_x))\n",
    "pyl.ylim((-max_y,max_y))\n",
    "\n",
    "pyl.scatter(reduced_tfidf_matr[:, 0], reduced_tfidf_matr[:, 1], 20)\n",
    "\n",
    "for doc in xrange(len(prepared_test_set)):\n",
    "    target_label = labels[doc]\n",
    "    x = reduced_tfidf_matr[doc, 0]\n",
    "    y = reduced_tfidf_matr[doc, 1]\n",
    "    pyl.annotate(target_label, (x,y))\n",
    "\n",
    "pyl.grid()\n",
    "pyl.show()    "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### -------------------------- Summary by improved \"TextRank\" --------------------------------------------------"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "WARNING:gensim.summarization.summarizer:Input text is expected to have at least 10 sentences.\n",
      "WARNING:gensim.summarization.summarizer:Input corpus is expected to have at least 10 documents.\n",
      "WARNING:gensim.summarization.summarizer:Input text is expected to have at least 10 sentences.\n",
      "WARNING:gensim.summarization.summarizer:Input corpus is expected to have at least 10 documents.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      " ****************** Summary for doc.#0 ********************* \n",
      "Several small and large prospective studies have found an association between gestational acetaminophen exposure and attention-deficit/hyperactivity disorder (ADHD)-like behaviors, use of ADHD medication, and ADHD diagnoses in offspring during childhood; the only negative study was a small investigation that examined only one aspect of attention as an outcome.\n",
      "However, since fever during pregnancy may itself be associated with adverse gestational outcomes, given the present level of uncertainty about the ADHD risk with acetaminophen, it is suggested that, until more data are available, the use of acetaminophen in pregnancy should not be denied in situations in which the need for the drug is clear.\n",
      "\n",
      "\n",
      " ****************** Summary for doc.#1 ********************* \n",
      "A randomized clinical trial conducted at 9 primary care clinics in Washington State suggests that collaborative care results in an increase of 0.04 quality-adjusted life-year over usual care at USD 883 above usual care, for a mean incremental cost-effectiveness ratio of USD 18239 per quality-adjusted life-year gained.\n",
      "The mean incremental cost-effectiveness ratio was $18239 (95% CI, dominant to $24408) per QALY gained, with dominant indicating that the intervention resulted in both a net cost savings and a net increase in QALYs. Collaborative care for adolescent depression appears to be cost-effective, with 95% CIs far below the strictest willingness-to-pay thresholds.\n",
      "\n",
      "\n",
      " ****************** Summary for doc.#2 ********************* \n",
      "In this national retrospective longitudinal cohort of almost 1.9 million adult inpatients in the Medicaid program, suicide risk during the first 90 days after hospital discharge was highest for patients with first-listed depressive disorders, followed by those with bipolar disorder, schizophrenia, and substance use disorders and lowest for patients with nonmental disorders.\n",
      "To describe the risk for suicide during the 90 days after hospital discharge for adults with first-listed diagnoses of depressive disorder, bipolar disorder, schizophrenia, substance use disorder, and other mental disorders in relation to inpatients with diagnoses of nonmental disorders and the general population.\n",
      "\n",
      "\n",
      " ****************** Summary for doc.#3 ********************* \n",
      "In a nationwide prospective cohort study of more than 1 million women living in Denmark, an increased risk for first use of an antidepressant and first diagnosis of depression was found among users of different types of hormonal contraception, with the highest rates among adolescents.\n",
      "All women and adolescents aged 15 to 34 years who were living in Denmark were followed up from January 1, 2000, to December 2013, if they had no prior depression diagnosis, redeemed prescription for antidepressants, other major psychiatric diagnosis, cancer, venous thrombosis, or infertility treatment.\n",
      "\n",
      "\n",
      " ****************** Summary for doc.#4 ********************* \n",
      "Adults meeting DSM-IV criteria for heroin dependence and treated with opioid medication (n = 27) and healthy controls (n = 26) were recruited between March 2013 and October 2013 and given a computer-based task to assess avoidance behavior.\n",
      "While groups did not differ on escape responding (hiding) during the aversive event, heroin-dependent men (but not women) made more avoidance responses during a warning signal that predicted the aversive event (analysis of variance, sex  group interaction, P = .007).\n",
      "Results suggest that, in male patients, differences in avoidance behavior cannot be easily explained by impaired task performance or by exaggerated motor activity.\n",
      "This study provides evidence for abnormal acquisition and extinction of avoidance behavior in opioid-dependent patients.\n",
      "\n",
      "\n",
      " ****************** Summary for doc.#5 ********************* \n",
      "To integrate all the randomized evidence from the available antipsychotics used for treatment-resistant schizophrenia by performing a network meta-analysis.\n",
      "At least 2 independent reviewers selected published and unpublished single- and double-blind RCTs in treatment-resistant schizophrenia (any study-defined criterion) that compared any antipsychotic (at any dose and in any form of administration) with another antipsychotic or placebo.\n",
      "Insufficient evidence exists on which antipsychotic is more efficacious for patients with treatment-resistant schizophrenia, and blinded RCTsin contrast to unblinded, randomized effectiveness studiesprovide little evidence of the superiority of clozapine compared with other second-generation antipsychotics.\n",
      "\n",
      "\n",
      " ****************** Summary for doc.#6 ********************* \n",
      "Cigarette Smoking and the Onset and Persistence of Panic Attacks During Mid-Adulthood in the United States: 19942005.\n",
      "The current study examined the relationship between cigarette smoking (daily) and risk of onset and persistence of panic attacks over a 10-year period among adults in mid-adulthood in the United States and whether quitting smoking reduced the risk for panic attacks.\n",
      "Moreover, smoking abstinence significantly reduced the risk of new-onset panic attacks (OR = 0.6 [95% CI, 0.40.97]) and persistence of panic attacks (OR = 0.2 [95% CI, 0.10.5]).\n",
      "The present data provide novel evidence that smoking is associated with an increased risk of panic attacks and that quitting smoking helps reduce such risk.\n",
      "\n",
      "\n",
      " ****************** Summary for doc.#7 ********************* \n",
      "To demonstrate the effectiveness of a Diabetes Prevention Programinspired 12-month behavioral intervention for patients with severe mental illness (SMI) and medication-associated obesity.\n",
      "122 outpatients with DSM-IVdiagnosed SMI taking antipsychotic medications who had  7% weight gain or body mass index (BMI) > 25 were randomized by computer-generated number to Lifestyle Balance treatment intervention (n = 60) or usual care control (n = 62) groups.\n",
      "Treatment was more effective than usual care control in treating medication-associated obesity, independent of SMI diagnosis, antipsychotic medication, and knowledge gained, suggesting that behavioral interventions are effective in SMI patients.\n",
      "\n",
      "\n",
      " ****************** Summary for doc.#8 ********************* \n",
      "Patient treatment preference may moderate treatment effect in major depressive disorder (MDD) studies.\n",
      "From a 14-week trial of chronic PTSD comparing prolonged exposure, relaxation therapy, and interpersonal psychotherapy, we report treatment preferences of the 110 randomized patients, explore preference correlates, and assess effects on treatment outcome.\n",
      "Patients recruited between 2008 and 2013 with chronic DSM-IV PTSD (Clinician-Administered PTSD Scale [CAPS] score  50) received balanced, scripted psychotherapy descriptions prerandomization and indicated their preferences.\n",
      "We hypothesized that patients randomized to preferred treatments would have better outcomes, and to unwanted treatment worse outcomes.\n",
      "Comorbidly depressed patients receiving unwanted treatment had worse final CAPS scores.\n",
      "\n",
      "\n",
      " ****************** Summary for doc.#9 ********************* \n",
      "Efficacy of Topiramate in the Treatment of Crack Cocaine Dependence: A Double-Blind, Randomized, Placebo-Controlled Trial.\n",
      "We performed a double-blind, randomized, placebo-controlled trial to assess the efficacy of topiramate in the treatment of crack cocaine dependence.\n",
      "Topiramate reduced the quantity of cocaine used (mean reduction = 3.108 g, P < .001), the frequency of cocaine use (mean = 0.784 times per week, P = .005), and the amount of money spent on cocaine (mean [US dollars] = $25.38, P = .015; this variable did not achieve statistical significance after Bonferroni correction) compared with the placebo during the 12 weeks (or 84 days) of the assessment.\n"
     ]
    }
   ],
   "source": [
    "summary_len_words = 100\n",
    "count = 0\n",
    "\n",
    "for doc in test_set:\n",
    "    summary = summarize(doc, word_count=summary_len_words)\n",
    "    print('\\n\\n ****************** Summary for doc.#{} ********************* '.format(count))\n",
    "    count += 1\n",
    "    print(summary)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### -------------------------- Summaries by algorithms: usual TextRank, LSA, Kullback–Leibler, LexRank ------------------------------------------"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "collapsed": false,
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " \n",
      " ************ Summaries for file Use of Acetaminophen (Paracetamol) During Pregnancy .txt. ************\n",
      "\n",
      " --------- Summary by usual TextRank algorithm ---------\n",
      "Several small and large prospective studies have found an association between gestational acetaminophen exposure and attention-deficit/hyperactivity disorder (ADHD)-like behaviors, use of ADHD medication, and ADHD diagnoses in offspring during childhood; the only negative study was a small investigation that examined only one aspect of attention as an outcome.\n",
      "In the light of the finding of a single study that infection and fever during pregnancy by themselves do not raise the ADHD risk, it appears possible that the use of acetaminophen during pregnancy is itself responsible for the increased risk of ADHD.\n",
      "However, since fever during pregnancy may itself be associated with adverse gestational outcomes, given the present level of uncertainty about the ADHD risk with acetaminophen, it is suggested that, until more data are available, the use of acetaminophen in pregnancy should not be denied in situations in which the need for the drug is clear.\n",
      "\n",
      " --------- Summary by LSA algorithm ---------\n",
      "Creditably, most of the studies adjusted analyses for many (but not all) confounds associated with ADHD risk.\n",
      "In the light of the finding of a single study that infection and fever during pregnancy by themselves do not raise the ADHD risk, it appears possible that the use of acetaminophen during pregnancy is itself responsible for the increased risk of ADHD.\n",
      "However, since fever during pregnancy may itself be associated with adverse gestational outcomes, given the present level of uncertainty about the ADHD risk with acetaminophen, it is suggested that, until more data are available, the use of acetaminophen in pregnancy should not be denied in situations in which the need for the drug is clear.\n",
      "\n",
      " --------- Summary by Kullback–Leibler algorithm ---------\n",
      "Use of Acetaminophen (Paracetamol) During Pregnancy and the Risk of Attention-Deficit/Hyperactivity Disorder in the Offspring.\n",
      "In the light of the finding of a single study that infection and fever during pregnancy by themselves do not raise the ADHD risk, it appears possible that the use of acetaminophen during pregnancy is itself responsible for the increased risk of ADHD.\n",
      "This suggests that acetaminophen may not be as safe in pregnancy as is widely believed.\n",
      "\n",
      " --------- Summary by LexRank algorithm ---------\n",
      "Use of Acetaminophen (Paracetamol) During Pregnancy and the Risk of Attention-Deficit/Hyperactivity Disorder in the Offspring.\n",
      "Importantly, one pivotal study also adjusted for pain, infection, inflammation, and fever to reduce confounding by indication; this study found a dose-dependent risk.\n",
      "However, since fever during pregnancy may itself be associated with adverse gestational outcomes, given the present level of uncertainty about the ADHD risk with acetaminophen, it is suggested that, until more data are available, the use of acetaminophen in pregnancy should not be denied in situations in which the need for the drug is clear.\n",
      "\n",
      " \n",
      " ************ Summaries for file Care for Adolescents with Depression in Primary Care Settings.txt. ************\n",
      "\n",
      " --------- Summary by usual TextRank algorithm ---------\n",
      "The Costs and Cost-effectiveness of Collaborative Care for Adolescents With Depression in Primary Care Settings.\n",
      "A randomized clinical trial conducted at 9 primary care clinics in Washington State suggests that collaborative care results in an increase of 0.04 quality-adjusted life-year over usual care at USD 883 above usual care, for a mean incremental cost-effectiveness ratio of USD 18239 per quality-adjusted life-year gained.\n",
      "To evaluate the costs and cost-effectiveness of a collaborative care model for treatment of adolescent major depressive disorder in primary care settings.\n",
      "\n",
      " --------- Summary by LSA algorithm ---------\n",
      "Even by the most conservative standards, the ROAD collaborative care model is a cost-effective approach for treating adolescent depression.\n",
      "A 12-month collaborative care intervention included an initial in-person engagement session, delivery of evidence-based treatments, and regular follow-up by master’s level clinicians.\n",
      "Of those screened, 105 youths met criteria for entry into the study, and 101 were randomized to the intervention (n=50) and usual care (n=51) groups.\n",
      "\n",
      " --------- Summary by Kullback–Leibler algorithm ---------\n",
      "A randomized clinical trial conducted at 9 primary care clinics in Washington State suggests that collaborative care results in an increase of 0.04 quality-adjusted life-year over usual care at USD 883 above usual care, for a mean incremental cost-effectiveness ratio of USD 18239 per quality-adjusted life-year gained.\n",
      "Collaborative care models have been shown to be effective in improving adolescent depressive symptoms, but there are few data on the effect of such a model on costs.\n",
      "To evaluate the costs and cost-effectiveness of a collaborative care model for treatment of adolescent major depressive disorder in primary care settings.\n",
      "\n",
      " --------- Summary by LexRank algorithm ---------\n",
      "The Costs and Cost-effectiveness of Collaborative Care for Adolescents With Depression in Primary Care Settings.\n",
      "A randomized clinical trial conducted at 9 primary care clinics in Washington State suggests that collaborative care results in an increase of 0.04 quality-adjusted life-year over usual care at USD 883 above usual care, for a mean incremental cost-effectiveness ratio of USD 18239 per quality-adjusted life-year gained.\n",
      "Overall health plan costs were not significantly different between the intervention ($5161; 95% CI, $3564-$7070)and usual care ($5752; 95% CI, $3814-$7952) groups.\n",
      "\n",
      " \n",
      " ************ Summaries for file Short-term Suicide Risk After Psychiatric Hospital Discharge.txt. ************\n",
      "\n",
      " --------- Summary by usual TextRank algorithm ---------\n",
      "In this national retrospective longitudinal cohort of almost 1.9 million adult inpatients in the Medicaid program, suicide risk during the first 90 days after hospital discharge was highest for patients with first-listed depressive disorders, followed by those with bipolar disorder, schizophrenia, and substance use disorders and lowest for patients with nonmental disorders.\n",
      "To describe the risk for suicide during the 90 days after hospital discharge for adults with first-listed diagnoses of depressive disorder, bipolar disorder, schizophrenia, substance use disorder, and other mental disorders in relation to inpatients with diagnoses of nonmental disorders and the general population.\n",
      "This national retrospective longitudinal cohort included inpatients aged 18 to 64 years in the Medicaid program who were discharged with a first-listed diagnosis of a mental disorder (depressive disorder, bipolar disorder, schizophrenia, substance use disorder, and other mental disorder) and a 10% random sample of inpatients with diagnoses of nonmental disorders.\n",
      "\n",
      " --------- Summary by LSA algorithm ---------\n",
      "Recently discharged psychiatric inpatients, especially those with mood disorders, are at exceptionally high short-term risk for suicide.\n",
      "Suicide rates per 100 000 person-years were determined for each study group during the 90 days after hospital discharge and the demographically matched US general population.\n",
      "After psychiatric hospital discharge, adults with complex psychopathologic disorders with prominent depressive features, especially patients who are not tied into a system of health care, appear to have a particularly high short-term risk for suicide.\n",
      "\n",
      " --------- Summary by Kullback–Leibler algorithm ---------\n",
      "This national retrospective longitudinal cohort included inpatients aged 18 to 64 years in the Medicaid program who were discharged with a first-listed diagnosis of a mental disorder (depressive disorder, bipolar disorder, schizophrenia, substance use disorder, and other mental disorder) and a 10% random sample of inpatients with diagnoses of nonmental disorders.\n",
      "Data were analyzed from March 5, 2015, to June 6, 2016.\n",
      "In the overall population of 1 861 194 adults (27% men; 73% women; mean [SD] age, 35.4 [13.1] years), suicide rates for the cohorts with depressive disorder (235.1 per 100000 person-years), bipolar disorder (216.0 per 100 000 person-years), schizophrenia (168.3 per 100 000 person-years), substance use disorder (116.5 per 100000 person-years), and other mental disorders (160.4 per 100000 person-years) were substantially higher than corresponding rates for the cohort with nonmental disorders (11.6 per 100000 person-years) or the US general population (14.2 per 100000 person-years).\n",
      "\n",
      " --------- Summary by LexRank algorithm ---------\n",
      "In this national retrospective longitudinal cohort of almost 1.9 million adult inpatients in the Medicaid program, suicide risk during the first 90 days after hospital discharge was highest for patients with first-listed depressive disorders, followed by those with bipolar disorder, schizophrenia, and substance use disorders and lowest for patients with nonmental disorders.\n",
      "This national retrospective longitudinal cohort included inpatients aged 18 to 64 years in the Medicaid program who were discharged with a first-listed diagnosis of a mental disorder (depressive disorder, bipolar disorder, schizophrenia, substance use disorder, and other mental disorder) and a 10% random sample of inpatients with diagnoses of nonmental disorders.\n",
      "The cohort included 770643 adults in the mental disorder cohort, 1090551 adults in the nonmental disorder cohort, and 370 deaths from suicide from January 1, 2001, to December 31, 2007.\n",
      "\n",
      " \n",
      " ************ Summaries for file Association of Hormonal Contraception With Depression.txt. ************\n",
      "\n",
      " --------- Summary by usual TextRank algorithm ---------\n",
      "Users of progestogen-only pills had an RR for first use of an antidepressant of 1.34 (95% CI, 1.27-1.40); users of a patch (norgestrolmin), 2.0 (95% CI, 1.76-2.18); users of a vaginal ring (etonogestrel), 1.6 (95% CI, 1.55-1.69); and users of a levonorgestrel intrauterine system, 1.4 (95% CI, 1.31-1.42).\n",
      "When the reference group was changed to those who never used hormonal contraception, the RR estimates for users of combined oral contraceptives increased to 1.7 (95% CI, 1.66-1.71).\n",
      "Users of progestogen-only pills had an RR for first use of an antidepressant of 1.34 (95% CI, 1.27-1.40); users of a patch (norgestrolmin), 2.0 (95% CI, 1.76-2.18); users of a vaginal ring (etonogestrel), 1.6 (95% CI, 1.55-1.69); and users of a levonorgestrel intrauterine system, 1.4 (95% CI, 1.31-1.42).\n",
      "\n",
      " --------- Summary by LSA algorithm ---------\n",
      "In a nationwide prospective cohort study of more than 1 million women living in Denmark, an increased risk for first use of an antidepressant and first diagnosis of depression was found among users of different types of hormonal contraception, with the highest rates among adolescents.\n",
      "To investigate whether the use of hormonal contraception is positively associated with subsequent use of antidepressants and a diagnosis of depression at a psychiatric hospital.\n",
      "With time-varying covariates, adjusted incidence rate ratios (RRs) were calculated for first use of an antidepressant and first diagnosis of depression at a psychiatric hospital.\n",
      "\n",
      " --------- Summary by Kullback–Leibler algorithm ---------\n",
      "Data were collected from January 1, 1995, to December 31, 2013, and analyzed from January 1, 2015, through April 1, 2016.\n",
      "A total of 1061997 women (mean [SD] age, 24.4 [0.001] years; mean [SD] follow-up, 6.4 [0.004] years) were included in the analysis.\n",
      "A total of 1 061 997 women (mean [SD] age, 24.4 [0.001] years; mean [SD] follow-up, 6.4 [0.004] years) were included in the analysis.\n",
      "\n",
      " --------- Summary by LexRank algorithm ---------\n",
      "In a nationwide prospective cohort study of more than 1 million women living in Denmark, an increased risk for first use of an antidepressant and first diagnosis of depression was found among users of different types of hormonal contraception, with the highest rates among adolescents.\n",
      "All women and adolescents aged 15 to 34 years who were living in Denmark were followed up from January 1, 2000, to December 2013, if they had no prior depression diagnosis, redeemed prescription for antidepressants, other major psychiatric diagnosis, cancer, venous thrombosis, or infertility treatment.\n",
      "Adolescents (age range, 15-19 years) using combined oral contraceptives had an RR of a first use of an antidepressant of 1.8 (95% CI, 1.75-1.84) and those using progestin-only pills, 2.2 (95% CI, 1.99-2.52).\n",
      "\n",
      " \n",
      " ************ Summaries for file Exaggerated Acquisition and Resistance to Extinction of Avoidance Behavior in Treated Heroin-Dependent Men.txt. ************\n",
      "\n",
      " --------- Summary by usual TextRank algorithm ---------\n",
      "Exaggerated Acquisition and Resistance to Extinction of Avoidance Behavior in Treated Heroin-Dependent Men.\n",
      "In rodents, opioid intake has been associated with abnormal acquisition and extinction of avoidance behavior.\n",
      "This study provides evidence for abnormal acquisition and extinction of avoidance behavior in opioid-dependent patients.\n",
      "\n",
      " --------- Summary by LSA algorithm ---------\n",
      "Adults meeting DSM-IV criteria for heroin dependence and treated with opioid medication (n = 27) and healthy controls (n = 26) were recruited between March 2013 and October 2013 and given a computer-based task to assess avoidance behavior.\n",
      "Results suggest that, in male patients, differences in avoidance behavior cannot be easily explained by impaired task performance or by exaggerated motor activity.\n",
      "Findings shed light on cognitive and behavioral manifestations of opioid addiction and may facilitate development of therapeutic approaches to help affected individuals.\n",
      "\n",
      " --------- Summary by Kullback–Leibler algorithm ---------\n",
      "While groups did not differ on escape responding (hiding) during the aversive event, heroin-dependent men (but not women) made more avoidance responses during a warning signal that predicted the aversive event (analysis of variance, sex × group interaction, P = .007).\n",
      "Heroin-dependent men were also slower to extinguish the avoidance response when the aversive event no longer followed the warning signal (P = .011).\n",
      "Interestingly, data suggest that abnormal avoidance is demonstrated only by male patients.\n",
      "\n",
      " --------- Summary by LexRank algorithm ---------\n",
      "For this task, subjects controlled a spaceship and could either gain points by shooting an enemy spaceship or hide in safe areas to avoid on-screen aversive events.\n",
      "While groups did not differ on escape responding (hiding) during the aversive event, heroin-dependent men (but not women) made more avoidance responses during a warning signal that predicted the aversive event (analysis of variance, sex × group interaction, P = .007).\n",
      "This study provides evidence for abnormal acquisition and extinction of avoidance behavior in opioid-dependent patients.\n",
      "\n",
      " \n",
      " ************ Summaries for file Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia.txt. ************\n",
      "\n",
      " --------- Summary by usual TextRank algorithm ---------\n",
      "At least 2 independent reviewers selected published and unpublished single- and double-blind RCTs in treatment-resistant schizophrenia (any study-defined criterion) that compared any antipsychotic (at any dose and in any form of administration) with another antipsychotic or placebo.\n",
      "In addition, relatively few RCTs were available for antipsychotics other than clozapine, haloperidol, olanzapine, and risperidone.\n",
      "Insufficient evidence exists on which antipsychotic is more efficacious for patients with treatment-resistant schizophrenia, and blinded RCTs—in contrast to unblinded, randomized effectiveness studies—provide little evidence of the superiority of clozapine compared with other second-generation antipsychotics.\n",
      "\n",
      " --------- Summary by LSA algorithm ---------\n",
      "At least 2 independent reviewers extracted all data into standard forms and assessed the quality of all included trials with the Cochrane Collaboration’s risk-of-bias tool.\n",
      "A pattern of superiority for olanzapine, clozapine, and risperidone was seen in other efficacy outcomes, but results were not consistent and effect sizes were usually small.\n",
      "Future clozapine studies with high doses and patients with extremely treatment-refractory schizophrenia might be most promising to change the current evidence.\n",
      "\n",
      " --------- Summary by Kullback–Leibler algorithm ---------\n",
      "To integrate all the randomized evidence from the available antipsychotics used for treatment-resistant schizophrenia by performing a network meta-analysis.\n",
      "Insufficient evidence exists on which antipsychotic is more efficacious for patients with treatment-resistant schizophrenia, and blinded RCTs—in contrast to unblinded, randomized effectiveness studies—provide little evidence of the superiority of clozapine compared with other second-generation antipsychotics.\n",
      "Future clozapine studies with high doses and patients with extremely treatment-refractory schizophrenia might be most promising to change the current evidence.\n",
      "\n",
      " --------- Summary by LexRank algorithm ---------\n",
      "To integrate all the randomized evidence from the available antipsychotics used for treatment-resistant schizophrenia by performing a network meta-analysis.\n",
      "At least 2 independent reviewers extracted all data into standard forms and assessed the quality of all included trials with the Cochrane Collaboration’s risk-of-bias tool.\n",
      "In the primary outcome (reported as standardized mean difference; 95% credible interval), olanzapine was more effective than quetiapine (−0.29; −0.56 to −0.02), haloperidol (−0.\n",
      "\n",
      " \n",
      " ************ Summaries for file Cigarette Smoking and the Onset and Persistence of Panic Attacks During Mid-Adulthood in the United States.txt. ************\n",
      "\n",
      " --------- Summary by usual TextRank algorithm ---------\n",
      "The current study examined the relationship between cigarette smoking (daily) and risk of onset and persistence of panic attacks over a 10-year period among adults in mid-adulthood in the United States and whether quitting smoking reduced the risk for panic attacks.\n",
      "Daily smoking in 1994 (OR = 1.9 [95% CI, 1.1–3.3]) and persistent daily smoking in 1994 and 2005 (OR = 2.6 [95% CI, 1.4–4.8]) were associated with a significantly increased likelihood of panic attacks in 2005.\n",
      "Moreover, smoking abstinence significantly reduced the risk of new-onset panic attacks (OR = 0.6 [95% CI, 0.4–0.97]) and persistence of panic attacks (OR = 0.2 [95% CI, 0.1–0.5]).\n",
      "\n",
      " --------- Summary by LSA algorithm ---------\n",
      "Cigarette Smoking and the Onset and Persistence of Panic Attacks During Mid-Adulthood in the United States: 1994–2005.\n",
      "The current study examined the relationship between cigarette smoking (daily) and risk of onset and persistence of panic attacks over a 10-year period among adults in mid-adulthood in the United States and whether quitting smoking reduced the risk for panic attacks.\n",
      "Logistic regressions were used to evaluate the associations between smoking status and the onset and persistence of panic attack after controlling for demographic characteristics and substance use problems.\n",
      "\n",
      " --------- Summary by Kullback–Leibler algorithm ---------\n",
      "Cigarette Smoking and the Onset and Persistence of Panic Attacks During Mid-Adulthood in the United States: 1994–2005.\n",
      "Data were drawn from the Midlife Development in the United States Survey (N = 2,101), a nationally representative sample of adults aged 25 to 74 years at baseline (wave 1, 1994–1995) who were followed up 10 years later at wave 2 (2004–2006).\n",
      "Psychiatric diagnoses were based on the Composite International Diagnostic Interview Short-Form (CIDI-SF [based on DSM-III-R criteria]) scales.\n",
      "\n",
      " --------- Summary by LexRank algorithm ---------\n",
      "Cigarette Smoking and the Onset and Persistence of Panic Attacks During Mid-Adulthood in the United States: 1994–2005.\n",
      "The current study examined the relationship between cigarette smoking (daily) and risk of onset and persistence of panic attacks over a 10-year period among adults in mid-adulthood in the United States and whether quitting smoking reduced the risk for panic attacks.\n",
      "Moreover, smoking abstinence significantly reduced the risk of new-onset panic attacks (OR = 0.6 [95% CI, 0.4–0.97]) and persistence of panic attacks (OR = 0.2 [95% CI, 0.1–0.5]).\n",
      "\n",
      " \n",
      " ************ Summaries for file Behavioral Interventions for Antipsychotic Medication Associated Obesity.txt. ************\n",
      "\n",
      " --------- Summary by usual TextRank algorithm ---------\n",
      "Behavioral Interventions for Antipsychotic Medication–Associated Obesity: A Randomized, Controlled Clinical Trial.\n",
      "122 outpatients with DSM-IV–diagnosed SMI taking antipsychotic medications who had ≥ 7% weight gain or body mass index (BMI) > 25 were randomized by computer-generated number to Lifestyle Balance treatment intervention (n = 60) or usual care control (n = 62) groups.\n",
      "Treatment was more effective than usual care control in treating medication-associated obesity, independent of SMI diagnosis, antipsychotic medication, and knowledge gained, suggesting that behavioral interventions are effective in SMI patients.\n",
      "\n",
      " --------- Summary by LSA algorithm ---------\n",
      "To demonstrate the effectiveness of a Diabetes Prevention Program–inspired 12-month behavioral intervention for patients with severe mental illness (SMI) and medication-associated obesity.\n",
      "This randomized, controlled, parallel, superiority study screened 225 volunteers from November 2005 to August 2008 at the VA Greater Los Angeles Healthcare System.\n",
      "122 outpatients with DSM-IV–diagnosed SMI taking antipsychotic medications who had ≥ 7% weight gain or body mass index (BMI) > 25 were randomized by computer-generated number to Lifestyle Balance treatment intervention (n = 60) or usual care control (n = 62) groups.\n",
      "\n",
      " --------- Summary by Kullback–Leibler algorithm ---------\n",
      "122 outpatients with DSM-IV–diagnosed SMI taking antipsychotic medications who had ≥ 7% weight gain or body mass index (BMI) > 25 were randomized by computer-generated number to Lifestyle Balance treatment intervention (n = 60) or usual care control (n = 62) groups.\n",
      "Our intention-to-treat analysis found significant differences in predicted trajectory of mean weight change between the groups over 12 months (P < .01), with treatment participants expected to lose an average 4.6 kg, while control participants would gain an average 0.6 kg.\n",
      "Both groups demonstrated statistically significant improvements in health knowledge quiz scores over time (P = .006), without significant difference between groups.\n",
      "\n",
      " --------- Summary by LexRank algorithm ---------\n",
      "Behavioral Interventions for Antipsychotic Medication–Associated Obesity: A Randomized, Controlled Clinical Trial.\n",
      "122 outpatients with DSM-IV–diagnosed SMI taking antipsychotic medications who had ≥ 7% weight gain or body mass index (BMI) > 25 were randomized by computer-generated number to Lifestyle Balance treatment intervention (n = 60) or usual care control (n = 62) groups.\n",
      "Treatment was more effective than usual care control in treating medication-associated obesity, independent of SMI diagnosis, antipsychotic medication, and knowledge gained, suggesting that behavioral interventions are effective in SMI patients.\n",
      "\n",
      " \n",
      " ************ Summaries for file Treatment Preferences of Psychotherapy Patients with Chronic PTSD.txt. ************\n",
      "\n",
      " --------- Summary by usual TextRank algorithm ---------\n",
      "From a 14-week trial of chronic PTSD comparing prolonged exposure, relaxation therapy, and interpersonal psychotherapy, we report treatment preferences of the 110 randomized patients, explore preference correlates, and assess effects on treatment outcome.\n",
      "We hypothesized that patients randomized to preferred treatments would have better outcomes, and to unwanted treatment worse outcomes.\n",
      "Eighty-seven patients (79%) voiced treatment preferences or disinclinations: 29 (26%) preferred prolonged exposure, 29 (26%) preferred relaxation therapy, and 56 (50%) preferred interpersonal psychotherapy (Cochran Q = 18.46, P < .001), whereas 29 (26%) were disinclined to prolonged exposure, 18 (16%) to relaxation therapy, and 3 (3%) to interpersonal psychotherapy (Cochran Q = 22.71, P < .001).\n",
      "\n",
      " --------- Summary by LSA algorithm ---------\n",
      "From a 14-week trial of chronic PTSD comparing prolonged exposure, relaxation therapy, and interpersonal psychotherapy, we report treatment preferences of the 110 randomized patients, explore preference correlates, and assess effects on treatment outcome.\n",
      "Comorbidly depressed patients receiving unwanted treatment had worse final CAPS scores.\n",
      "Despite explanations emphasizing prolonged exposure’s greater empirical support, patients significantly preferred interpersonal psychotherapy.\n",
      "\n",
      " --------- Summary by Kullback–Leibler algorithm ---------\n",
      "Treatment Preferences of Psychotherapy Patients With Chronic PTSD.\n",
      "Little research has addressed preference in posttraumatic stress disorder (PTSD); almost none has assessed actual patients’ PTSD psychotherapy preferences.\n",
      "Patients recruited between 2008 and 2013 with chronic DSM-IV PTSD (Clinician-Administered PTSD Scale [CAPS] score ≥ 50) received balanced, scripted psychotherapy descriptions prerandomization and indicated their preferences.\n",
      "\n",
      " --------- Summary by LexRank algorithm ---------\n",
      "Little research has addressed preference in posttraumatic stress disorder (PTSD); almost none has assessed actual patients’ PTSD psychotherapy preferences.\n",
      "From a 14-week trial of chronic PTSD comparing prolonged exposure, relaxation therapy, and interpersonal psychotherapy, we report treatment preferences of the 110 randomized patients, explore preference correlates, and assess effects on treatment outcome.\n",
      "Comorbidly depressed patients receiving unwanted treatment had worse final CAPS scores.\n",
      "\n",
      " \n",
      " ************ Summaries for file Efficacy of Topiramate in the Treatment of Crack Cocaine Dependence.txt. ************\n",
      "\n",
      " --------- Summary by usual TextRank algorithm ---------\n",
      "The primary outcome measures were detection of benzoylecgonine in the urine, study retention, frequency of cocaine smoking, amount of cocaine use, and mean amount of money spent on cocaine per week.\n",
      "Topiramate reduced the quantity of cocaine used (mean reduction = −3.108 g, P < .001), the frequency of cocaine use (mean = −0.784 times per week, P = .005), and the amount of money spent on cocaine (mean [US dollars] = −$25.38, P = .015; this variable did not achieve statistical significance after Bonferroni correction) compared with the placebo during the 12 weeks (or 84 days) of the assessment.\n",
      "However, the differences in reductions between the 2 groups in the quantity of cocaine used, the frequency of cocaine use, and money spent on cocaine over time (time × group interaction) were present only during the first 4 weeks, and none of these variables by 12 weeks.\n",
      "\n",
      " --------- Summary by LSA algorithm ---------\n",
      "Efficacy of Topiramate in the Treatment of Crack Cocaine Dependence: A Double-Blind, Randomized, Placebo-Controlled Trial.\n",
      "We performed a double-blind, randomized, placebo-controlled trial to assess the efficacy of topiramate in the treatment of crack cocaine dependence.\n",
      "Longitudinal assessment revealed that retention was not significant (odds ratio [OR] = 1.072, P = .908) between the 2 groups.\n",
      "\n",
      " --------- Summary by Kullback–Leibler algorithm ---------\n",
      "The primary outcome measures were detection of benzoylecgonine in the urine, study retention, frequency of cocaine smoking, amount of cocaine use, and mean amount of money spent on cocaine per week.\n",
      "The study was conducted from February 2013 to February 2014.\n",
      "However, the differences in reductions between the 2 groups in the quantity of cocaine used, the frequency of cocaine use, and money spent on cocaine over time (time × group interaction) were present only during the first 4 weeks, and none of these variables by 12 weeks.\n",
      "\n",
      " --------- Summary by LexRank algorithm ---------\n",
      "The subjects were randomly assigned to either a topiramate group (subjects received 50–200 mg of topiramate per day for 12 weeks) or a control group (subjects received placebo).\n",
      "The primary outcome measures were detection of benzoylecgonine in the urine, study retention, frequency of cocaine smoking, amount of cocaine use, and mean amount of money spent on cocaine per week.\n",
      "Topiramate reduced the quantity of cocaine used (mean reduction = −3.108 g, P < .001), the frequency of cocaine use (mean = −0.784 times per week, P = .005), and the amount of money spent on cocaine (mean [US dollars] = −$25.38, P = .015; this variable did not achieve statistical significance after Bonferroni correction) compared with the placebo during the 12 weeks (or 84 days) of the assessment.\n"
     ]
    }
   ],
   "source": [
    "# to regulate the length of summary\n",
    "SENTENCES_COUNT = 3\n",
    "\n",
    "stemmer = Stemmer(\"english\")\n",
    "tr = [0.0, 0.0, 0.0]\n",
    "lsa = [0.0, 0.0, 0.0]\n",
    "kl = [0.0, 0.0, 0.0]\n",
    "lrs = [0.0, 0.0, 0.0]\n",
    "metrics = [tr, lsa, kl, lrs]\n",
    "summaries_mapping = {0: 'usual TextRank', 1: 'LSA', 2: 'Kullback–Leibler', 3: 'LexRank'}\n",
    "\n",
    "for file in os.listdir(PATH_TEST_SET):\n",
    "    if file.endswith(\".txt\"):\n",
    "        print('\\n \\n ************ Summaries for file {}. ************'.format(file))\n",
    "        parser = PlaintextParser.from_file(PATH_TEST_SET + file, Tokenizer(\"english\"))\n",
    "        summarizers = [\n",
    "            TextRankSummarizer(stemmer), \n",
    "            Summarizer(stemmer), \n",
    "            KL(stemmer), \n",
    "            LRS(stemmer)\n",
    "        ]\n",
    "     \n",
    "        for summarizer in summarizers:\n",
    "            summarizer.stop_words = get_stop_words(\"english\")\n",
    "        \n",
    "        summaries = [[]] * 4\n",
    "        for i in range(len(summarizers)):\n",
    "            print('\\n --------- Summary by {} algorithm ---------'.format(summaries_mapping[i]))\n",
    "            for sentence in summarizers[i](parser.document, SENTENCES_COUNT):\n",
    "                summaries[i].append(sentence)\n",
    "                print(sentence)\n",
    "\n",
    "            metrics[i][0] += Rogue.rouge_1(summaries[i], parser.document.sentences)\n",
    "            metrics[i][1] += Rogue.rouge_2(summaries[i], parser.document.sentences)\n",
    "            metrics[i][2] += Rogue.rouge_n(summaries[i], parser.document.sentences, 3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "labels = ['TextRank', 'LSA', 'KL', 'LexRank']\n",
    "for i, metric in enumerate(metrics):\n",
    "    plt.plot([1,2,3], metric, linewidth=1, label=labels[i])\n",
    "    \n",
    "plt.grid(True)\n",
    "plt.axis('tight')\n",
    "plt.title('Summarization quality')\n",
    "plt.xlabel('ROUGE metric')\n",
    "plt.ylabel('Score')\n",
    "plt.legend()\n",
    "plt.savefig('G:/vkr_docs_to_start/shizic_articles_test_set/summarization_ROUGE.pdf')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 2",
   "language": "python",
   "name": "python2"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.11"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 0
}
